Journals / Türk Biyokimya Dergisi / 2013 / Cilt: 38 - Sayı: 2

Regulation of mitogen activated protein kinases through heterotrimeric G proteins

Mitojenle etkinleşen protein kinazların heterotrimerik G proteinleri ile düzenlenmesi

Pages
218–228
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Each of mitogen-activated protein kinase pathways consists of three distinct kinases, namely an upstream respectively; mitogen-activated protein kinase kinase kinase , mitogen-activated protein kinase kinase and mitogen-activated protein kinase

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Heterotrimeric G proteins are known as G proteins, consist of α, β, and γ subunits.
📊
Key Findings & Data:The amino acid identity of the α subunits has been used as basis for the classification of G proteins into four families Gs, Gi, Gq, and G12.
💡
Conclusion & Impact:Each of mitogen-activated protein kinase pathways consists of three distinct kinases, namely an upstream respectively; mitogen-activated protein kinase kinase kinase , mitogen-activated protein kinase kinase and mitogen-activated protein kinase
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Heterotrimeric G proteins are known as G proteins, consist of α, β, and γ subunits. G protein mediated signaling is employed by virtually all cells in the mammalian organism and is centrally involved in diverse physiological functions such as perception of sensory information, modulation of synaptic transmission, hormone release and actions, regulation of cell contraction and migration, or cell growth and differentiation. The amino acid identity of the α subunits has been used as basis for the classification of G proteins into four families Gs, Gi, Gq, and G12. G proteins stimulate distinct downstream effectors including enzymes, ion channels and small GTPase, thus regulating multiple signaling pathways including those involved in the activation of mitogen-activated protein kinase pathways. Mitogen-activated protein kinases are a family that constitute signaling pathways involved in processes that control gene expression, cell division, cell survival, apoptosis, metabolism, differentiation and motility. The mitogen-activated protein kinase family includes ERK1/2, c-Jun N-terminal kinazlar 1, 2 ve 3, p38MAPK a, b, g, and d, and ERK5 as classical mitogen-activated protein kinases, and ERK3, ERK4 NLK, and ERK7 as atypical mitogen-activated protein kinases. Each of mitogen-activated protein kinase pathways consists of three distinct kinases, namely an upstream respectively; mitogen-activated protein kinase kinase kinase , mitogen-activated protein kinase kinase and mitogen-activated protein kinase

Özet

G proteinleri olarak bilinen heterotrimerik G proteinleri ?, ? ve ? alt birimlerinden oluşur. G protein aracılı sinyal iletimi memeli organizmasındaki tüm hücrelerde kullanılır ve duyusal bilginin algılanması, sinaptik iletinin düzenlenmesi, hormon serbestlenmesi ve etkileri, hücre kasılmasının ve göçünün düzenlenmesi, hücre büyümesi ve farklılaşmasının düzenlenmesi gibi farklı fizyolojik fonksiyonlar ile ilişkilidir. G proteinlerinin, ? alt birimleri amino asit benzerliklerine göre temel olarak Gs, Gi, Gq, ve G12 olmak üzere dört aileye ayrılır. G proteinleri enzimler, iyon kanalları ve küçük GTPaz' lar gibi aşağı efektör moleküllerini uyararak, mitojenle-etkinleşen protein kinazlar da dahil pek çok sinyal yolağını düzenlerler. Mitojenle-etkinleşen protein kinaz ailesi gen ekspresyonu, hücre bölünmesi, hücre canlılığı, apopitoz, metabolizma, farklılaşma ve motilite ile ilişkili süreçlerin kontrolündeki sinyal iletimi yolaklarını oluştururlar. Mitojenle-etkinleşen protein kinaz ailesi, klasik mitojenleetkinleşen protein kinazlar olarak adlandırılan ERK1/2, c-Jun N-terminal kinazlar 1, 2 ve 3, p38MAPK a, b, g ve d ve ERK5 ile atipik mitojenle-etkinleşen protein kinazlar olarak adlandırılan ERK3, ERK4 NLK ve ERK7 MAPK' ları içerir. Mitojenle-etkinleşen protein kinaz yolaklarının her biri en üstteki kinazdan itibaren sırasıyla; mitojenle-etkinleşen protein kinaz kinaz kinaz, mitojenle-etkinleşen potein kinaz kinaz, ve mitojenle-etkinleşen protein kinaz olmak üzere üç farklı kinazı içerir

🔖

Cite This Article

KÜÇÜKKAYA, B., AFRASYAP, L. (2022). Regulation of mitogen activated protein kinases through heterotrimeric G proteins. Türk Biyokimya Dergisi, Cilt: 38 - Sayı: 2, 218–228. https://ajindex.com/articles/621285

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Offermans S, Simon M1. Organization of transmembrane signaling by heterotrimeric proteins. Cancer Surv 1997; 27:177-98.
  2. Küçükkaya B, Kan B. Heterotrimerik Proteinleri. Turk Biochem 2007; 32(1):39-50.
  3. Wettschureck N, Offermans S. Mammalian proteins and their cell type specific functions. Physiol Rev 2005; 85(4):]159-204. Patel TB. Single transmembrane spanning heterotrimeric protein-coupled receptors and their signaling cascades. Pharmacol Rev 2004; 56(3):371-85.
  4. Rajagopal S, Kim J, Ahn S, Craig S, Lam CM, et al. Betaarrestin-cbut not protein-mediated signaling by the “decoy” receptor CXCR7. Proc Natl Acad Sci 2010; 107(2):628-32
  5. Landry Y, Gies JP. Heterotrimeric proteins control diverse pathways of transmembrane signaling, base for drug discovery. Mini Rev Med Chem 2002; 2(4):361-372.
  6. Yanamadal V, Negoro H, Denker BM. Heterotrimeric proteins and apoptosis: intersecting signaling pathways leading to context dependent phenotypes. Curr Mol Med 2009; 9(5):527-45.
  7. Hepler JR, Gilman AG. proteins. Trends Biochem Sci 1992; 17(10):383-7. Simon M1, Strathmann MP, Gautam N. Diversity of proteins in signal transduction. Science 1991; 252(5007):802-8.
  8. Cabrera-Vera TM, Vanhauwe J, Thomas TO, Medkova M, Preininger A, et al. Insights into protein structure, function and regulation. Endocr Rev 2003; 24(6):765-81. lbegbu AO, Mullaney I, Fyfe L, MacBean D. The roles of guanine nucleotide binding proteins in health and disease. Br Pharmacol and Toxicology 2011; 2(1):12-20. Stryer L. Cyclic GMP cascade of vision. Annu Rev Neurosci 1986; 9:87-119.
  9. Luttrell LM. ‘Location, location’: activation and targeting of MAP kinases by protein-coupled receptors. Mol Endocrinol 2003;30(2):117-26.
  10. Denis C, Sauliere A, Galandrin S, Senard JM, Gales C. Probing heterotrimeric protein activation: applications to biased ligands. Curr Pharm Des 2012; 18(2):128-44.
  11. Lin Y, Smrcka AV. Understanding molecular recognition by protein [3y subunits on the path to pharmacological targeting. Mol Pharmacol 2011; 80(4):551-7. Traynor J. u—Opioid receptors and regulators of protein signaling (RGS) proteins: from symposium on new concepts in mu-opioid pharmacology. Drug Alcohol Depend 2012; 121(3): 173-80.
  12. Dohlman HG, Thorners J. RGS proteins and signaling by heterotrimeric proteins. Biol Chem 1997; 272(7):3871-4.
  13. Coulomb P, Meloche S. Atypical mitogen-activated protein kinases: structure, regulation and functions. Biochim Biophys Acta 2007; 1773(8):1376-87. [19] Goldsmith ZG, Dhanasekaran DN. protein regul